Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement ... (ented by BostonHealthcare in the UK and ...)

HOME >> BIOLOGY >> TECHNOLOGY

Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability

Date:10/28/2008

ented by Boston Healthcare in the UK and US.

About Boston Healthcare

Boston Healthcare assists emerging and established biopharmaceutical, medical device and diagnostic companies in gaining a competitive advantage in the health care marketplace by helping them unlock the value of innovative drugs, devices, and diagnostics. These companies rely on Boston Healthcare to create opportunities, navigate complexity, grow their businesses, and achieve objectives through reimbursement, business development, and market strategies. Clients draw on Boston Healthcare's unique approach to gain a real-world edge in a highly competitive health care environment.

Contact:

Michal Taton

Boston Healthcare

(617) 912-5119

mtaton@bostonhealthcare.com

SOURCE Boston Healthcare Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2008
2. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
3. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
4. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
5. Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
6. Boston Scientific to Participate in UBS Global Life Sciences Conference
7. Boston Scientific Announces Court Decision
8. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
9. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
10. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
11. TechCFO Adds Gary Strickland as Partner in Boston Office

Post Your Comments:

(Date:11/24/2009)..., , TSX VENTURE: HTL , TORONTO, Nov... (TSX-V: HTL), formerly Calotto Capital Inc., a le...uments for the stem cell research and fertility cl...cial results for the third quarter ended September...enue was $1.46 million compared with $1.43 million...

(Date:11/24/2009)..., , SAN DIEGO, Nov. 24, 2009 /PRNewsw...daq: ARNA ) announced today that the company is...nual Health Care Conference on December 1, 2009 at...at the New York Palace Hotel in New York City. Jac...cer, is scheduled to provide an overview of the co...

(Date:11/24/2009)...,, BOZEN,Italy,November24/PRNewswire/--Healt...njointventurewithagroupofselected,investors.Thisre...e,nameHealthRoboticsCanada,Inc.andwillmarket,insta...ncept,whichincludesthe,revolutionaryproductofferin...oboticsCanadaInc.willalsoprovideassistanceonan"asn...

(Date:11/24/2009)..., Chemical Abstracts Serv...on, reports that China,s patent office is now the ...cations in chemistry. China trailed Japan,s patent...ion (WIPO), and the United States Patent and Trade...ssed the USPTO in 2005, WIPO in 2006, and exceeded...

[0] Hamilton Thorne announces third quarter results [0] Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference [0] Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada [0] China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information

... 12 Anthera Pharmaceuticals, Inc., a,privately he...mmatory drugs,announced today that it has complete...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib (A-0...of an Acute,Coronary Syndrome (ACS) event. , "...

... Pharmasset, Inc. (Nasdaq: VRUS ) announced toda...have agreed with the FDA on the final design for a... of hepatitis C (HCV), slated to initiate in the f...at R7128 is advancing into a large phase 2b trial,...ief Medical Officer. "R7128 is the most advanced n...

...nuary 12 , - Reflects Strong International Gr...ding IP Management Specialist and Legal Support Se...llectual property,( http://www.cpaglobal.com ) (IP...outsourced legal support services, has today marke...ew brand worldwide. , Founded in 1969 as a spe...

Other Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2 Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3 Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2 Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3 Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4 Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5 CPA Global Marks 40th Anniversary With Launch of New Brand 2 CPA Global Marks 40th Anniversary With Launch of New Brand 3

Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients CPA Global Marks 40th Anniversary With Launch of New Brand

(Date:11/25/2009)...ital to your health as what you eat, found researc... Their experiments in mice revealed that the daily...verthe body,s metabolic clearinghouseis mostly con...dian clock as conventional wisdom had it. , "If...umber of genes completely independent of the circa...

(Date:11/24/2009)...es from collapsing have been true life-savers. But...ed -- once the arteries are strengthened, they bec... but to leave them in place. , Prof. Meital Zilb...dical Engineering has developed a new patent-pendi... needed, then dissolves. , "Our new composite fi...

(Date:11/24/2009)...debate. A high-profile study a few years ago sugge...on from trees and leaves, evidence for a very clos...ems. , But new research from the University of W...ae provide a much richer diet for fish and other a...week in the Proceedings of the National Academy o...

Breaking Biology News(10 mins):Feeding the clock 2 Feeding the clock 3 A coating for life 2 Fish food fight: Fish don't eat trees after all, says new study 2 Fish food fight: Fish don't eat trees after all, says new study 3 Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 1 Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 2 Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 3 Go to the doctor 3F Only if Im really sick 52314 1 Go to the doctor 3F Only if Im really sick 52314 2 Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1 Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2 Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3

[0] Feeding the clock [0] A coating for life [0] Fish food fight: Fish don't eat trees after all, says new study

...INGTON, Va., June 10 Stanley, Inc. (NYSE:,SXE), a...ssional services,to the U.S. federal government, a...ve agreement to acquire Oberon Associates, Inc. (O...d information technology services,company. The pur...cash,subject to certain working capital and other ...

...Scientists at the Institute of Food Research have ...re vulnerable to the development of tumours. , W... Biotechnology and Biological Sciences Research Co...ntrol these changes and delay or reverse the onset...hat play a role in the very earliest stages of col...

...Monash University research into heavy metal contam... the Gippsland Lakes has revealed high mercury lev.... , Researchers from the School of Biological Sc...he dolphins were within a range considered to caus...er than mercury levels found in populations around...

Other Biology News:Stanley to Acquire Oberon Associates 2 Stanley to Acquire Oberon Associates 3 Stanley to Acquire Oberon Associates 4 'Addicted' cells provide early cancer diagnosis 2 Mercury contamination found in stranded Victorian dolphins 2

Stanley to Acquire Oberon Associates 'Addicted' cells provide early cancer diagnosis Mercury contamination found in stranded Victorian dolphins

CD25 MicroBeads, non-human primate from Miltenyi Biotec

...tors are designed for enhanced translation of clon...s, e.g. rabbit reticulocyte lysate. The maps for p...a(+) with the following exceptions: pCITE-2b(+) is... and Xcm I sites. Subtract 7 bp from all sites bey...

Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences

Flp-In T-REx Core Kit from Invitrogen

Biology Products:

CD25 MicroBeads, non-human primate from Miltenyi Biotec pCITE-2a(+) DNA from Novagen Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences Flp-In T-REx Core Kit from Invitrogen

Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement ...(ented by BostonHealthcare in the UK and ...)